Low dose of HCG to prevent OHSS

Reproductive BioMedicine Online

Volumn 15, Issue 3, 2007, Pages 354-

  Craft, Ian ^a   Hodgson, David ^a  

^a London Fertility Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; FOLLITROPIN; GONADORELIN ANTAGONIST; GONADORELIN DERIVATIVE; HUMAN MENOPAUSAL GONADOTROPIN;

DISEASE SEVERITY; DOWN REGULATION; HIGH RISK POPULATION; HUMAN; INCIDENCE; LETTER; LOW DRUG DOSE; OOCYTE; OVARY FOLLICLE MATURATION; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION;

EID: 34548791871     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)60350-1     Document Type: Letter

References (3)

1. Abdalla H, Ah-Moye M, Brinsden P et al. 1987 The effect of the dose of human chorionic gonadotrophin and the type of gonadotrophin stimulation on oocyte recovery rates in an in-vitro fertilization programme. Fertility and Sterility 486, 958-963.
2. Craft I, Gorgy A, Hill J et al. 1999 Will GnRH antagonist provide new hope for patients considered 'difficult responders' to GnRH agonist protocols? Human Reproduction 14, 2959-2962.
3. Nargund G, Hutchinson L, Scaramuzzi R, Campbell S 2007 Low-dose HCG is useful in preventing OHSS in high-risk women without adversely affecting the outcome of IVF cycles. Reproductive BioMedicine Online 14, 682-685.